The study, to be led by the University of
California, Irvine, investigates how digital tools can aid clinical
outcomes
Anthem, Inc. announced today a new study that examines how the
use of everyday devices, like Apple Watch and iPhone, may help
individuals with asthma better self-manage their condition for
improved clinical outcomes. The virtual study is being conducted by
University of California, Irvine (UCI) and was designed in
collaboration with Apple, Inc. CareEvolution is the study
technology partner responsible for building the study app and
enabling collection of the study data.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200916005283/en/
Anthem, Inc. announced today a new study
that examines how the use of everyday devices, like Apple Watch and
iPhone, may help individuals with asthma better self-manage their
condition for improved clinical outcomes. (Graphic: Business
Wire)
Launching in the fall, the two-year, randomized controlled study
will enroll participants from Anthem-affiliated health plans who
have been clinically diagnosed with asthma. Nearly 25 million
Americans are currently diagnosed with some form of the chronic
condition, and, when uncontrolled, asthma can lead to permanent
lung damage, hospitalizations and even premature death.
Additionally, nearly 1.8 million emergency department visits each
year are counted as a result of asthma attacks.
“As part of our mission of improving people’s lives, we are
making it easier for consumers to proactively manage their health
through our digital-first approach to delivering healthcare
solutions and services,” said Rajeev Ronanki, Chief Digital Officer
at Anthem, Inc. “Millions of Americans are struggling with their
asthma condition each day and we’re thrilled to collaborate with
UCI, Apple and CareEvolution on studying new solutions.”
The primary goal of the study is to investigate clinical changes
in outcomes associated with the use of the new digital tools in
self-management of asthma. Additionally, the study will explore if
data collected from everyday use devices such as iPhone and Apple
Watch can help predict asthma exacerbation or serve as potential
digital biomarkers of asthma control.
“Personalized medicine and improving the health of populations
are based on similar principles. The human body contains critical
information – data – necessary to diagnose and treat our patients,”
said Dr. Steve Goldstein, vice chancellor for health affairs at
UCI. “Through innovation and emerging technologies, we are able to
harness that data, and by coupling it with an individual’s
environment and experiences, chart pathways to lifelong health and
well-being. Public-private collaborations like this one with UCI,
Anthem and Apple, are fueled by the passion to serve and shared
entrepreneurial spirit, and are helping us establish new standards
of whole-person care for our patients.”
“The Digital Asthma Study brings together Apple Watch’s
innovative technology with an engaging app-based self-management
experience to investigate how consumers can better manage and
control a prevalent condition,” says Myoung Cha, Apple’s Head of
Health Strategic Initiatives. “We hope this study can help the
medical community produce new insights about asthma control and can
identify effective digital tools that can help empower people
around the world to better manage their condition.”
About the Study
Eligible participants will be invited to enroll in the study.
Participants who choose to enroll in the study will receive a
BedditTM Sleep Monitor and an Apple Watch.
While there is no cure for asthma, studies have shown that many
people can improve their symptoms and reduce exacerbation risk
through self-management behaviors including avoiding triggers -
such as pollen, mold or smoke - medication adherence, and correct
inhaler technique.1 However, asthma self-management is often far
from ideal, with some data suggesting that less than 50 percent of
individuals with asthma are well-controlled.2 Scalable and
effective solutions are needed to empower patients to improve
asthma self-management and reduce the need for costly asthma
care.3
To investigate the impact of digital intervention on asthma
symptoms and healthcare utilization, the active group of the study
will have access to the digital asthma tool, designed for the
study. The digital asthma tool includes daily symptom and trigger
tracking to provide awareness of asthma control and personalized
nudges based on changes in signals from their Apple Watch including
activity, heart rate, the new Blood Oxygen feature and other health
metrics. Participants will also receive timely curated education
materials and prescription refill resources.
Designed with patient privacy in mind, the study offers the
participants complete control over their data, and transparency
into how the data will be used and shared. Data will be stored on
the participants’ device and shared through a direct, encrypted
connection with CareEvolution.
About Anthem, Inc.
Anthem is a leading health benefits company dedicated to
improving lives and communities, and making healthcare simpler.
Through its affiliated companies, Anthem serves more than 106
million people, including more than 42 million within its family of
health plans. We aim to be the most innovative, valuable and
inclusive partner. For more information, please visit
www.antheminc.com or follow @AnthemInc on Twitter.
About the University of California, Irvine
Founded in 1965, UCI is the youngest member of the prestigious
Association of American Universities. The campus has produced three
Nobel laureates and is known for its academic achievement, premier
research, innovation and anteater mascot. Led by Chancellor Howard
Gillman, UCI has more than 36,000 students and offers 222 degree
programs. It’s located in one of the world’s safest and most
economically vibrant communities and is Orange County’s
second-largest employer, contributing $5 billion annually to the
local economy. For more on UCI, visit www.uci.edu.
1https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487370/
2https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634481/#CR7
3https://www.nature.com/articles/s41533-017-0056-4
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200916005283/en/
Media Contacts: Anthem, Inc Maryrose Lombardo
Maryrose.Lombardo@anthem.com
University of California, Irvine Nicole Feldman
nefeldma@uci.edu
Anthem (NYSE:ANTM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Anthem (NYSE:ANTM)
Historical Stock Chart
From Apr 2023 to Apr 2024